GPCR/G protein
G protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors, that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.
Products for GPCR/G protein
- GIP Receptor(2)
- FFAR1 (GPR40)(7)
- 5-HT Receptor(238)
- Urotensin-II Receptor(10)
- CCK2 Receptors(7)
- P2Y Receptor(25)
- EP4 Receptor(3)
- CRF1 Receptors(6)
- Melatonin Receptors(9)
- LPL Receptor(1)
- Adenosine Receptor(54)
- VIP Receptors(7)
- OX Receptor(15)
- Chemokine Receptors(16)
- Neurotensin Receptors(7)
- Prostanoid Receptors(21)
- CCK1 Receptors(5)
- Adrenergic Receptor(136)
- GPR119(5)
- Calcium-Sensing Receptor(3)
- Cannabinoid Receptor(36)
- Angiotensin Receptor(21)
- GPR120(2)
- Protease-Activated Receptors(9)
- PAF Receptors(3)
- Sigma Receptor(24)
- NK3 Receptor(6)
- NPY Receptors(23)
- Glucagon Receptor(16)
- Leukotriene Receptor(9)
- Bombesin Receptors(14)
- Sphingosine(14)
- CXCR(16)
- NOP Receptor(21)
- GPR55(5)
- Galanin Receptors(11)
- Endothelin Receptor(11)
- GPR35(7)
- Glucocorticoid Receptor(17)
- Calcitonin and Related Receptors(10)
- Bradykinin Receptors(12)
- mGluR(11)
- Adenosine Kinase(2)
- GPR109A(2)
- GPCR19(1)
- Non-selective CRF(7)
- LTD4 Receptor(1)
- Secretin Receptors(1)
- Melanocortin (MC) Receptors(16)
- ETB Receptors(5)
- NK2 Receptors(7)
- LPA Receptor(5)
- S1P receptor inhibitor(5)
- CCR2(5)
- Hydroxycarboxylic Acid Receptors(5)
- PACAP Receptors(3)
- Melanin-concentrating Hormone Receptors(7)
- Vasopressin Receptor(10)
- Somatostatin Receptor(15)
- TSH Receptor(1)
- Peptide Receptors(8)
- Ghrelin Receptors(9)
- ETA Receptors(3)
- Orphan 7-TM Receptors(6)
- Oxytocin Receptors(4)
- Ras(6)
- Heterotrimeric(1)
- CysLT1 receptor(1)
- Motilin Receptor(4)
- Acetylcholine(3)
- Prostaglandin Receptor(4)
- GHSR(4)
- EBI2/GPR183(1)
- Gonadotropin-Releasing Hormone Receptors(3)
- Orexin(3)
- Apelin Receptor(5)
- CRF2 Receptors(3)
- Calcimimetic Agent(2)
- Adrenergic Transporters(5)
- CaSR(3)
- EP1 Receptor(1)
- Sensory Neuron-Specific Receptors(1)
- 17,20-lyase(3)
- Adenosine Deaminase(3)
- NK Receptor(1)
- PGD2 Receptor(1)
- GLUT1(1)
- RGS(2)
- GPR44(1)
- Adiponectin Receptor(1)
- ERRγ(1)
- Cat.No. Product Name Information
- BCC5870 GIP (human) Gastric Inhibitory Peptide (GIP), human is thought to act as an inhibitor of gastric functions.
- BCC3702 TAK-875 Fasiglifam (TAK-875) is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 72 nM.
- BCC7218 AS 19 AS19 is a potent, selective 5-HT7 receptor agonist with an IC50 value of 0.83 nM and a Ki of 0.6 nM. AS19 is selective for 5-HT7 over 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT5A receptors (Kis = 89.7 nM, 490 nM, 6.6 nM and 98.5 nM, respectively). AS19 enhances memory consolidation and reverses Scopolamine- or Dizocilpine-induced amnesia.
- BCC8010 GSK 1562590 hydrochloride
- BCC5958 Gastrin I (human) Gastrin-1, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
- BCC7804 NF 546 NF546 is a selective non-nucleotide P2Y11 agonist with a pEC50 of 6.27. NF546 stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
- BCC1757 MK-2894 MK-2894 is a highly potent and selective second generation EP4 antagonist.
- BCC1758 MK-2894 sodium salt MK-2894 sodium salt is a highly potent and selective second generation EP4 antagonist.
- BCC7178 Zacopride hydrochloride
- BCC7604 CP 376395 hydrochloride
- BCC6618 N-Acetyltryptamine
- BCC5438 LPA2 antagonist 1 LPA2 antagonist 1 is a LPA2 antagonist with an IC50 of 17 nM.
- BCC6649 DPCPX
- BCC7599 PSB 0788
- BCC5968 [D-p-Cl-Phe6,Leu17]-VIP
- BCC1760 MK-4305
- BCC6366 CTCE 9908
- BCC5845 Kinetensin (human) Kinetensin is a neurotensin-like peptide isolated from pepsin-treated human plasma.
- BCC7156 L-655,240
- BCC3786 GSK1292263 GSK1292263 is a novel GPR119 receptor agonist used for the treatment of type 2 diabetes.
- BCC7319 Devazepide Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders.
- BCC4329 Maprotiline HCl Maprotiline hydrochloride is a selective noradrenalin re-uptake inhibitor and a tetracyclic antidepressant.
- BCC7716 (±)-5'-Chloro-5'-deoxy-ENBA Highly selective A1 agonist
- BCC1732 MBX-2982 MBX-2982 is a selective, orally-available G protein-coupled receptor 119 (GPR119) agonist.
- BCC7521 Atipamezole hydrochloride Atipamezole hydrochloride is a synthetic α2-adrenoceptor antagonist with a Ki of 1.6 nM.
- BCC4344 Bisoprolol fumarate (±)-Bisoprolol (hemifumarate) is a selective type β1 adrenergic receptor blocker.
- BCC7157 CGS 15943 CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. .
- BCC7973 Strontium chloride
- BCC7800 MRS 2768 tetrasodium salt
- BCC6282 COR 170
- BCC4091 Tranilast Sodium Tranilast is an antiallergic agent.
- BCC1599 GPR120 modulator 1 GPR120 modulator 1 is useful for modulating G protein-coupled receptor 120 (GPR120).
- BCC1600 GPR120 modulator 2 GPR120 modulator 2 is useful for modulating G protein-coupled receptor 120 (GPR120).
- BCC6281 Q94 hydrochloride
- BCC6095 PSB 0739
- BCC7335 WEB 2086 Apafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM.
- BCC6728 Spiroxatrine
- BCC5759 BMY 14802 hydrochloride
- BCC6921 Senktide Senktide is a tachykinin NK3 receptor agonist.
- BCC6165 TC-G 1004
- BCC5909 DAPTA DAPTA is a synthetic peptide, functions as a viral entry inhibitor by targeting selectively CCR5, and shows potent anti-HIV activities.
- BCC6041 Parstatin (human)
- BCC6042 Parstatin (mouse)
- BCC7456 BIBP 3226 trifluoroacetate BIBP3226 TFA is a potent and selective neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist, with Kis of 1.1, 79, and 108 nM for rNPY Y1, hNPFF2, and rNPFF, respectively. BIBP3226 TFA displays anxiogenic-like effect.
- BCC7258 Glucagon-like peptide 1 (7-36) amide (human, rat) Glucagon-Like Peptide (GLP) I (7-36), amide, human (Human GLP-1-(7-36)-amide) is a physiological incretin hormone that stimulates insulin secretion.
- BCC6822 MDL 11,939
- BCC4881 Zafirlukast Zafirlukast is a potent orally active leukotriene D4 (LTD4) receptor antagonist.
- BCC6912 A 61603 hydrobromide
- BCC6299 PF 04418948 PF-04418948 is an orally active, potent and selective prostaglandin EP2 receptor antagonist with an IC50 of 16 nM.
- BCC5844 [D-Phe12]-Bombesin
- BCC6020 [D-Phe12,Leu14]-Bombesin
- BCC7598 PSB 603
- BCC6234 IT1t dihydrochloride IT1t dihydrochloride is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM.
- BCC7722 CYM 5442 hydrochloride CYM5442 is a potent, highly-selective and orally active sphingosine 1-phosphate (S1P1) receptor agonist with an EC50 of 1.35 nM. CYM5442 is inactive against S1P2, S1P3, S1P4, and S1P5. CYM5442 activates S1P1-dependent p42/p44-MAPK phosphorylation. CYM5442 exerts retinal neuroprotection. CYM5442 can easily penetrate the central nervous system (CNS).
- BCC7021 RX 821002 hydrochloride
- BCC1158 Plerixafor (AMD3100) Plerixafor (AMD 3100) is a selective CXCR4 antagonist with an IC50 of 44 nM. Plerixafor, an immunostimulant and a hematopoietic stem cell (HSC) mobilizer, is an allosteric agonist of CXCR7. Plerixafor inhibits HIV-1 and HIV-2 replication with an EC50 of 1-10 nM.
- BCC5885 des-His1-[Glu9]-Glucagon (1-29) amide
- BCC4161 MCOPPB trihydrochloride MCOPPB 3Hcl is a nociceptin receptor agonist with pKi of 10.07; weaker activity at other opioid receptors.
- BCC7084 Oleylethanolamide Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis.
- BCC5998 BIM 23042 Selective neuromedin B receptor antagonist (NMB-R, BB1)
- BCC5762 Galanin (1-15) (porcine, rat)
- BCC6947 (S)-(+)-Niguldipine hydrochloride
- BCC7094 SR 59230A hydrochloride SR59230A hydrochloride is a potent, selective, and blood-brain barrier penetrating β3-adrenergic receptor antagonist with IC50s of 40, 408, and 648 nM for β3, β1, and β2 receptors, respectively.
- BCC7183 Altanserin hydrochloride
- BCC6959 Neuropeptide Y 13-36 (porcine)
- BCC4326 Dexmedetomidine Dexmedetomidine is a sedative medication used by intensive care units and anesthetists.
- BCC5928 Galanin (1-29) (rat, mouse)
- BCC4090 Losartan Losartan is an angiotensin II receptor antagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.
- BCC8076 MK-571 sodium salt hydrate MK-571 sodium salt is a selective, orally active leukotriene D4 receptor antagonist, with Kis of 0.22 and 2.1 nM in guinea pig and human lung membranes.
- BCC7334 MK 571 MRP1 inhibitor; also CysLT1 (LTD4) inverse agonist
- BCC5720 Sarafotoxin S6b
- BCC7876 ML 145 ML 145 is a selective GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM, but not for the related GPR55 orphan receptor. GPR35 is expressed by various cells of the immune system and it may has potential as a therapeutic target in inflammatory disease.
- BCC6053 M 1145
- BCC7260 RS 102895 hydrochloride RS102895 hydrochloride is a potent CCR2 antagonist, with an IC50 of 360 nM, and shows no effect on CCR1.
- BCC5713 Endothelin 3 (human, rat) Endothelin-3, human, mouse, rabbit, rat is a 21-amino acid vasoactive peptide that binds to G-protein-linked transmembrane receptors, ET-RA and ET-RB.
- BCC5876 Xenin 8
- BCC7290 LY 255283
- BCC4775 Dexamethasone acetate Dexamethasone acetate (Dexamethasone 21-acetate) is a glucocorticoid receptor agonist. Dexamethasone acetate has the potential for ophthalmic infections treatment.
- BCC7338 CGH 2466 dihydrochloride Anti-inflammatory agent. Inhibitor of PDE4 and p38 MAPK, also adenosine receptor antagonist
- BCC6826 Luzindole Luzindole (N-0774) is a selective melatonin receptor antagonist. Luzindole preferentially targets MT2 (Mel1b) over MT1 (Mel1a) with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively. Luzindole suppresses experimental autoimmune encephalomyelitis (EAE), and exerts antidepressant-like activity.
- BCC5869 PHM 27 (human)
- BCC7477 L-365,260
- BCC5995 [Phe8Ψ(CH-NH)-Arg9]-Bradykinin
- BCC7517 LP 12 hydrochloride
- BCC7401 Tocrifluor T1117
- BCC1780 MTEP hydrochloride MTEP hydrochloride is a potent, selective and non-competitive mGlu5 antagonist with an IC50 of 5 nM and a Ki of 16 nM. MTEP hydrochloride produces antiparkinsonian-like effects.
- BCC5905 ABT 702 dihydrochloride ABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM).
- BCC6961 Galanin (1-30) (human) Galanin (1-30), human is a 30-amino acid neuropeptide, and acts as an agonist of GalR1 and GalR2 receptors, with Kis of both 1 nM.
- BCC7959 N,N-Dimethylsphingosine
- BCC4987 PF-05212384 (PKI-587) Gedatolisib (PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ, and mTOR with IC50s of 0.4 nM, 5.4 nM and 1.6 nM, respectively. PKI-587 is equally effective in both complexes of mTOR, mTORC1 and mTORC2.
- BCC7246 SDZ 205-557 hydrochloride
- BCC7143 SB 206553 hydrochloride
- BCC5724 CGRP 8-37 (human) HCGRP-(8-37) is a human calcitonin gene-related peptide (hCGRP) fragment and also an antagonist of CGRP receptor.
- BCC5390 INT-777 INT-777 is a potent TGR5 agonist with an EC50 of 0.82 μM.
- BCC5791 CRF (6-33)
- BCC1475 CGS 21680 CGS 21680 is a selective adenosine A2A receptor agonist, with a Ki of 27 nM.
- BCC2035 Verlukast
- BCC1965 SRT3109 SRT3109 is an antagonist of CXCR2, with a pIC50 of 8.2, and used in the research of chemokine mediated diseases.
- BCC1966 SRT3190 SRT3190 is an antagonist of CXCR2, used in the research of chemokine mediated diseases.
- BCC7807 WAY 208466 dihydrochloride